Pieris Pharmaceuticals, Inc.
USD13.60
-2.51 (-15.58%)
CEO
Stephen S. Yoder
IPO Date
2015-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.04
Prev. Close
$16.11
Day Low
$13.26
Day High
$15.35
52W Low
$6.20
52W High
$22.32
Market Cap
$0.02B
Volume
0.05M
| -1.7 |
| 31 Dec 2023 | FY | 2.4% | -57.3% | -91.7% | -63.5% | 0.00 | 3.24 | -0.7 |
| 31 Dec 2022 | FY | 89.3% | -120.7% | -111.9% | -32.7% | 0.47 | 2.01 | -2.5 |
| 31 Dec 2021 | FY | 92.5% | -138.0% | -85.4% | -28.2% | 0.27 | 2.52 | -5.6 |
| 31 Dec 2020 | FY | -58.7% | -127.0% | -120.0% | -35.5% | 0.55 | 3.42 | -3.7 |
| 31 Dec 2019 | FY | -18.8% | -51.3% | -46.3% | -16.8% | 0.32 | 4.26 | -7.7 |
| 31 Dec 2018 | FY | 100.0% | -91.9% | -67.0% | -18.9% | 0.00 | 2.82 | -5.3 |
| 31 Dec 2017 | FY | 100.0% | -69.8% | -153.2% | -17.0% | 0.00 | 1.96 | -18.8 |
| 31 Dec 2016 | FY | 100.0% | -391.0% | -90.4% | -65.0% | 0.00 | 3.90 | -2.6 |
| -3.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -29.3% | -16.9% | 0.00 | 6.49 | -3.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -19.8% | -12.8% | 0.00 | 7.67 | -4.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -14.7% | -10.3% | 0.00 | 8.84 | -0.0 |
| 31 Dec 2024 | Q4 | -1260.4% | 11443.4% | -9.7% | -6.9% | 0.00 | 7.33 | -1.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -17.7% | -14.1% | 0.00 | 4.82 | -1.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -19.2% | -14.3% | 0.00 | 3.95 | -0.9 |
| 31 Mar 2024 | Q1 | 156.6% | -9230.2% | -22.3% | -16.6% | 0.00 | 3.92 | -0.9 |
| 31 Dec 2023 | Q4 | -242.9% | -352.9% | -17.1% | -11.9% | 0.00 | 3.24 | -1.0 |